Cytek Biosciences to Participate in Upcoming Investor Conferences
Cytek Biosciences (Nasdaq: CTKB) has announced its participation in two major investor conferences in November 2024. The company will present at the Guggenheim Inaugural Healthcare Conference in Boston on November 11 at 11:00 a.m. ET, featuring a fireside chat. Additionally, they will deliver a presentation at the UBS Global Healthcare Conference in Rancho Palos Verdes on November 13 at 4:15 p.m. PT. Both presentations will be accessible via live and archived webcasts on the company's investor relations website.
Cytek Biosciences (Nasdaq: CTKB) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel novembre 2024. L'azienda presenterà alla Guggenheim Inaugural Healthcare Conference a Boston l'11 novembre alle 11:00 ora ET, con un'intervista informale. Inoltre, terranno una presentazione alla UBS Global Healthcare Conference a Rancho Palos Verdes il 13 novembre alle 16:15 ora PT. Entrambe le presentazioni saranno disponibili tramite webcast live e registrati sul sito web delle relazioni con gli investitori dell'azienda.
Cytek Biosciences (Nasdaq: CTKB) ha anunciado su participación en dos importantes conferencias para inversores en noviembre de 2024. La empresa presentará en la Conferencia Inaugural de Salud de Guggenheim en Boston el 11 de noviembre a las 11:00 a.m. ET, con una charla informal. Además, llevarán a cabo una presentación en la Conferencia Global de Salud de UBS en Rancho Palos Verdes el 13 de noviembre a las 4:15 p.m. PT. Ambas presentaciones estarán disponibles a través de webcasts en vivo y grabados en el sitio web de relaciones con inversores de la empresa.
Cytek Biosciences (Nasdaq: CTKB)는 2024년 11월에 두 개의 주요 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 11월 11일 오전 11:00 ET에 보스턴에서 열리는 구겐하임 건강 관리 회의에서 Fireside 채팅을 포함한 발표를 할 것입니다. 또한 11월 13일 오후 4:15 PT에 Rancho Palos Verdes에서 열리는 UBS 글로벌 건강 관리 회의에서 발표를 진행할 것입니다. 두 발표 모두 회사의 투자자 관계 웹사이트를 통해 실시간 및 기록된 웹캐스트로 제공될 예정입니다.
Cytek Biosciences (Nasdaq: CTKB) a annoncé sa participation à deux grandes conférences pour investisseurs en novembre 2024. L'entreprise présentera à la Conférence Inaugurale sur la Santé de Guggenheim à Boston le 11 novembre à 11h00 ET, avec une discussion informelle. De plus, ils donneront une présentation à la Conférence Mondiale sur la Santé de UBS à Rancho Palos Verdes le 13 novembre à 16h15 PT. Les deux présentations seront accessibles via des webdiffusions en direct et enregistrées sur le site des relations avec les investisseurs de la société.
Cytek Biosciences (Nasdaq: CTKB) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 11. November um 11:00 Uhr ET bei der Guggenheim Inaugural Healthcare Conference in Boston einen Vortrag halten, der ein Fireside-Chat umfasst. Darüber hinaus werden sie am 13. November um 16:15 Uhr PT eine Präsentation bei der UBS Global Healthcare Conference in Rancho Palos Verdes halten. Beide Präsentationen sind sowohl über Live- als auch aufgezeichnete Webcasts auf der Investor-Relations-Website des Unternehmens zugänglich.
- None.
- None.
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences in November.
- Guggenheim Inaugural Healthcare Conference in Boston, MA
Fireside chat on Monday, November 11, 2024, at 11:00 a.m. Eastern Time
- UBS Global Healthcare Conference in Rancho Palos Verdes, CA
Presentation on Wednesday, November 13, 2024, at 4:15 p.m. Pacific Time
Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com.
About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora™ CS; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
pgoodson@cytekbio.com
FAQ
When is Cytek Biosciences (CTKB) presenting at the Guggenheim Healthcare Conference 2024?
What time is Cytek Biosciences (CTKB) presenting at the UBS Global Healthcare Conference 2024?
How can investors access Cytek Biosciences (CTKB) conference presentations in November 2024?
